Efficacy, safety and tolerability of multiple doses of valsartan in children with hypertension with or without chronic kidney disease

Update Il y a 5 ans
Reference: EUCTR2011-005991-40

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate if a dose dependent reduction in MSBP exists when comparing two doses of valsartan solution over a 6wk period in children 1-5 years old with hypertension with or without CKD.


Inclusion criteria

  • Pediatric Hypertension With or Without CKD